RSS

Aptar Pharma

Not even 12 cm of snowfall could deter the hardy visitors to Pharmapack (well mostly) on day one and it certainly didn’t impact the amount of innovations from the show floor, which is expected to continue. Here is our brief round-up for day two more

News

Here, we feature a sneak peek preview of some of the companies that will exhibiting at this year’s CPhI event. more

Technology

Joachim Koerner, director e-Device, R&D Prescription Division, Aptar Pharma, discusses intranasal drug delivery and how an integrated electronic lockout device can assist with patient adherence and help prevent drug misuse. more

Opinion

A recent partnership to address the challenge of monitoring adherence in ophthalmic clinical trials was formed between Aptar Pharma and Kali Care. Here, Sina Fateh and Sai Shankar discuss this alliance further. more

, Opinion

Manufacturer of drug delivery systems for nasal applications, Aptar Pharma, has announced the installation of a new assembly machine for its Child-Resistant and Senior-Friendly Classic Nasal Pumps at the Congers site in North America. more

Technology

Ophthalmic Squeeze Dispenser

Courtesy of Allergan

Aptar Pharma’s innovative and patented preservative-free multidose Ophthalmic Squeeze Dispenser is now available for the first time for patients in the US prescription market using Allergan’s Restasis MultiDose 0.05%. more

News

Aptar-Pharma-.gif

Aptar Pharma Congers - Courtesy of Aptar Pharma

The new expansion for Aptar Pharma’s Congers site (New York, USA) was inaugurated on 20 March. more

News

Aptar Pharma has signed an exclusive development and license agreement with BD Becton, Dickinson and Company more

News

Aptar Pharma’s Prohaler is a smart DPI that has been developed with the patient in mind. This, says Aptar Pharma, makes it intuitive and simple to use by all asthma and COPD patients more

Technology

Aptar Pharma has obtained a State Food and Drug Administration (SFDA) import license approval to deliver its preservative-free multi-dose systems to customers in China. more

News

Aptar Pharma will unveil its Prohaler — the smart DPI for optimal patient compliance. more

News

RDD Asia 2014 seeks to link Asian regulators, industrial and academic scientists, clinicians and business professionals with their international counterparts, together working toward the goal of advancing inhaled and nasal drug therapy worldwide. more

Aptar Pharma Prescription Division will present and discuss the latest data from a number of user studies carried out with its Pro-Ject auto-injector at this year’s Pharmapack Europe. more

Technology

Aptar Pharma Prescription division presented Twister, its latest Dry Powder Inhaler (DPI), at international trade fair Pharmapack Europe. more

Technology

Jean-Marc Pardonge has been appointed as the new President of Aptar Pharma’s Prescription Division, a specialist in the development and manufacture of nasal and pulmonary drug delivery devices. more

Technology